SCHEDULE: Titan Trust Exits Entire DarioHealth Stake
Beneficial Ownership Report
Titan Trust 2024 I has reported the complete disposition of its 2.5 million pre-split shares in DarioHealth Corp. during Q3 2025.
Summary
- Titan Trust 2024 I has disposed of 100% of its beneficial ownership in DarioHealth Corp. during the three months ended September 30, 2025.
- The disposition involved 2,499,618 shares of common stock, which represents the pre-20-to-1 reverse stock split amount implemented by DarioHealth Corp. on August 28, 2025.
- These shares were initially issued to Titan Trust 2024 I on August 14, 2025, upon the cashless exercise of a third warrant dated February 15, 2024.
- Following the disposition, Titan Trust 2024 I beneficially owns 0 shares, representing 0% of DarioHealth Corp.'s common stock.
Sentiment
Score: 3
Explanation: The complete disposition of a significant stake by an institutional investor can signal a lack of confidence or a strategic portfolio reallocation, which is generally viewed negatively by the market.
Negatives
- The complete disposition of a significant stake by an institutional investor like Titan Trust 2024 I could be perceived negatively by the market, potentially signaling a lack of confidence or a strategic portfolio reallocation.
Future Outlook
The filing does not contain any forward-looking statements or guidance from DarioHealth Corp. or the reporting person regarding the issuer's future performance.
Industry Context
This filing reports a specific change in beneficial ownership and does not provide broader industry context or trends. It reflects an institutional investor's decision to fully divest from DarioHealth Corp.
Stakeholder Impact
- Shareholders may react negatively to the news of a significant institutional holder completely exiting their position, potentially leading to downward pressure on the stock price.
Key Dates
| Date | Description |
|---|---|
| 2024-02-15 | Date of the third warrant. |
| 2025-08-14 | Date of issuance of 2,499,618 shares to Titan Trust 2024 I upon cashless exercise of a warrant. |
| 2025-08-28 | Date DarioHealth Corp. implemented a 20-to-1 reverse stock split. |
| 2025-09-30 | Date of event which requires filing of this statement, marking the end of the period during which the disposition occurred. |
| 2025-10-09 | Date the Schedule 13G/A filing was signed by Titan Trust 2024 I. |
Recommendation
sellThe complete divestment by a significant institutional investor like Titan Trust 2024 I suggests a lack of conviction or a strategic shift away from DarioHealth Corp., which could put downward pressure on the stock price. Investors should consider this signal when evaluating their positions.
Keywords
DarioHealth, Titan Trust, Schedule 13G, beneficial ownership, stock disposition, reverse stock split, institutional investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.